TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

63.90$ +3.8% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for MBX Biosciences, Inc. (MBX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 24 · -2.2 % 24 Q4 24 · 19.9 % 24 Q1 25 · 7.8 % 25 Q2 25 · 24.7 % 25 Q3 25 · 7.4 % 25 Q4 25 · 17.9 % 25 Q1 26 · 12.1 % 26 Q2 26 · -14.7 % 26

EPS estimate beaten

Full history 6 of 9 quarters (67%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/27/2026 MBX Biosciences, Inc. (MBX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 MBX Biosciences, Inc. (MBX): Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/13/2026 MBX Biosciences, Inc. (MBX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?